Mochida Pharmaceutical Co., Ltd. (TYO:4534)

Japan flag Japan · Delayed Price · Currency is JPY
3,450.00
+35.00 (1.02%)
May 29, 2026, 3:30 PM JST
Market Cap122.30B +11.8%
Revenue (ttm)116.95B +11.2%
Net Income7.90B +39.0%
EPS222.93 +39.0%
Shares Out 35.45M
PE Ratio15.48
Forward PEn/a
Dividend80.00 (2.32%)
Ex-Dividend DateMar 30, 2026
Volume139,300
Open3,415.00
Previous Close3,415.00
Day's Range3,395.00 - 3,450.00
52-Week Range2,859.00 - 3,965.00
Beta0.07
Analystsn/a
Price Targetn/a
Earnings DateMay 15, 2026

About Mochida Pharmaceutical

Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Epadel for hyperlidemia and arteriosclerosis obliterans; Urece for gout and hyperuricemia; Treprost for the treatment of pulmonary arterial hypertension and p... [Read more]

Sector Healthcare
Founded 1913
Employees 1,508
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4534
Full Company Profile

Financial Performance

In fiscal year 2026, Mochida Pharmaceutical's revenue was 116.95 billion, an increase of 11.21% compared to the previous year's 105.16 billion. Earnings were 7.90 billion, an increase of 39.01%.

Financial Statements